Call Extraction: CDL-MedScout Touch Base

DDX ID: 0027 Date: 2025-12-04 Duration: ~26 minutes Participants: Phil Cranmer — CDL Nuclear. Kathryn White (going on maternity leave), Meaghan DePeter (taking over as primary CSM) — MedScout. Call type: Regular check-in with CSM handoff and product feedback. Triage: Moderate. Mostly platform logistics (export training, performance issues, handoff mechanics), but Phil’s internal champion management approach and the phased rollout gating logic are fingerprint-worthy. 3 distinct insights.

Distinct Insights

1. Phil gates rollout on product readiness to protect his internal credibility

What: Phil explicitly said he won’t push MedScout to Lynette’s team until two specific product enhancements are delivered: “I want to make a push once those two enhancements are done. We make a quick push to Lynette and her team.” When platform performance degraded during the call, his reaction was: “Let’s hope Lynette doesn’t log in right now.” He also asked Meaghan to warn him if performance wasn’t fixed by his call with Patrick the next day: “If, for some reason, it’s not let me know so I can push Patrick off. I don’t want him logging in and…”

So what: Phil treats platform rollout as a credibility bet. He has invested political capital internally to advocate for MedScout, and a bad first experience for Lynette or Patrick would cost him that capital. This means CDL’s adoption pattern isn’t “buy licenses, tell everyone to use it.” It’s staged and gated: Phil validates first, then selectively onboards stakeholders when he’s confident the product will make a good impression. This tells us CDL’s internal champion (Phil) is both an accelerator and a bottleneck. Product issues don’t just delay adoption — they create risk for Phil personally, which makes him more conservative about when he exposes new users. Any vendor selling to CDL needs to understand that Phil’s willingness to advocate depends on his confidence that the product won’t embarrass him.

Speaker credibility: Phil, internal champion and national operations leader. Very high — he’s describing his actual rollout strategy, not hypotheticals. Scope: Company-wide adoption pattern. Motion: Both (affects rollout to both private practice and hospital teams).

2. Phil buffers between vendor and internal stakeholders to get unfiltered feedback

What: When Meaghan offered to join Phil’s feedback call with Patrick, Phil declined: “No, no, no, I don’t want to do that. I’ll tell you why. I just want, I want it to feel like a safe environment for him and I just want to just keep it small. So he can just be brutally honest with me. I feel like not that I don’t cause I’ll feed. I’ll give you the feedback. I’ll tell you exactly what he says, but I don’t want him to sugar coat it because you’re on.”

So what: Phil acts as a translation layer between his sales team and vendors. He collects unfiltered internal feedback privately, then relays it to the vendor in his own framing. This serves two purposes: (1) he gets honest assessments from skeptical users like Patrick who might soften their criticism in front of the vendor, and (2) he controls the narrative — he can prioritize which feedback gets escalated and how it’s positioned. For MedScout, this means Phil is the single source of truth for CDL’s product experience, but his translation may filter or reframe things. For the fingerprint, it reveals CDL has internal users who are skeptical about platform adoption (Patrick “waffling on functionality”) and Phil is managing that skepticism actively rather than forcing adoption top-down.

Speaker credibility: Phil. Very high — this is a deliberate management approach, not offhand. Scope: Company-wide stakeholder management. Motion: Both.

3. Phil’s quarterly reporting reveals the metrics CDL tracks for market intelligence

What: Phil showed a spreadsheet where he manually pulls quarterly data from MedScout exports and creates trend line charts. He said: “On that second tab, you guys give me the breakdown by quarter. So I then come in here and populate it and then I get these pretty trend lines.” He wants quarter-over-quarter trending, not just year-over-year. His framing: “How do you give the functionality to now analyze data and turn data into insights or information that now can lead to some action?”

So what: CDL doesn’t just use claims data for one-time targeting. Phil tracks procedure volumes quarterly to identify trends — markets growing or shrinking, competitive shifts, territory performance changes. The fact that he builds this manually in Excel every quarter means it’s important enough to justify the labor, but the specific metrics he’s trending (procedure volumes by code set, by geography, quarter-over-quarter) reveal what CDL considers leading indicators for their business. If SPECT volume is declining in a market, that could mean (a) a competitor placed PET there and is converting volume, or (b) referral patterns are shifting. If SPECT volume is growing, that’s an expansion opportunity. Phil wants this as a “national view” — he’s monitoring the overall market, not just individual territories. This positions him as CDL’s market intelligence function, not just a sales operations role.

Speaker credibility: Phil, showing his actual workflow. Very high. Scope: National-level market intelligence. Motion: Both.

Transcription Notes

“Catherine” appears in transcript as Phil’s name for Kathryn White — consistent with other transcripts.
Patrick — referenced without last name. From context across transcripts, this is Patrick on the health system team. He was “waffling on functionality” after RSNA.
Meaghan’s phone number provided: 512-200-2925 (MedScout work line).
Cole mentioned as “our ZoomInfo guy” — CDL team member managing ZoomInfo contact intelligence.
No term bank errors detected in this transcript.